Pfizer seeks approval of its COVID-19 pill
WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home. The company’s filing comes as new infections are rising once again in the United ...